FDA Partnering With Medco To Study Genetics, Rx Treatments

August 20, 2008

FDA and pharmacy benefit manager Medco Health Solutions are collaborating on a two-year, pharmacogenomics-based study that will examine the relationship of patients’ genetic composition with the medications they are prescribed, the Wall Street Journal reports. (California Healthline)